Candidates possibly involved in modulating T cell activity include CD28/CD80, ICOS/ICOSL, OX-40/OX-40L, and B7-H6/NKp30, but very little is known as to their role in tumor–immune communication [13]. The gene discussed is CD28; the disease is neoplasm.